Planta Medica, Inhaltsverzeichnis Planta Med 1986; 52(5): 374-377DOI: 10.1055/s-2007-969189 Full Papers © Georg Thieme Verlag Stuttgart · New York In-Vitro-5-Lipoxygenasehemmung durch Eclipta alba Extrakte und das Coumestan-Derivat Wedelolacton In Vitro 5-Lipoxygenase Inhibition by Eclipta alba Extracts and the Coumestan Derivative WedelolactoneH. Wagner, B. Fessler Institut für Pharmazeutische Biologie der Universität München, Karlsstr. 29, D-8000 München 2, Bundesrepublik Deutschland. Artikel empfehlen Abstract als PDF herunterladen(opens in new window) Artikel einzeln kaufen(opens in new window) Abstract In the search for potent and selective 5-lipoxygenase-inhibitors, extracts of medicinal plants were screened for their potency of inhibiting the formation of inflammatory acting products of arachidonic acid metabolism using a porcine-leukocytes test system. The coumestan derivative wedelolactone isolated from Eclipta alba (L.) Hassk. and Wedelia calendulacea Less. has been found as a potent and selective 5-lipoxygenase-inhibitor with an IC50 of 2,5 µMol. As found by chemoluminescence, wedelolactone inhibits 5-lipoxygenase by an oxygen radical scavenger mechanism. PDF (378 kb)